GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Jetema Co 216080.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

5,700

-2.23%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩76.90bn

FY2017FY2025

Net income

−₩6.60bn

FY2017FY2025

Free cash flow

−₩4.80bn

FY2017FY2025

Shareholders' equity

₩65.46bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₩76.90bn₩68.52bn₩58.72bn₩45.99bn₩33.22bn₩20.66bn₩13.30bn₩11.21bn₩8.17bn
Research and development₩10.03bn₩9.81bn₩10.22bn₩6.26bn₩3.91bn₩5.05bn₩6.85bn——
Operating income₩3.82bn———₩2.28bn−₩8.49bn−₩10.74bn−₩4.55bn−₩4.00bn
Net income−₩6.60bn−₩188.3m₩13.97bn₩1.46bn₩10.88bn−₩9.33bn−₩14.72bn−₩15.70bn−₩5.56bn
Diluted earnings per share-177.45-5.26782.5581.68612.64-530.95-906.79-2,765.95-1,035.82

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₩209.14bn₩222.72bn₩244.23bn₩188.35bn₩147.93bn₩66.86bn₩62.29bn₩51.29bn₩18.97bn
Cash and short-term investments—₩23.90bn₩46.22bn₩20.87bn₩75.20bn₩16.94bn₩10.04bn₩14.01bn₩1.87bn
Total liabilities₩144.13bn₩151.29bn₩171.17bn₩131.41bn₩93.36bn₩25.30bn₩28.35bn₩56.33bn₩15.18bn
Debt₩50.10bn₩119.11bn₩123.04bn₩107.41bn₩57.38bn₩15.79bn₩14.57bn₩18.59bn₩11.83bn
Shareholders' equity₩65.46bn₩72.28bn₩71.51bn₩56.95bn₩54.56bn₩41.56bn₩33.94bn−₩5.04bn₩3.79bn
Shares outstanding37m36m18m18m18m18m16m6m5m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₩11.05bn₩3.72bn₩6.88bn₩14.18bn₩6.16bn₩1.57bn−₩8.11bn−₩5.93bn−₩1.58bn
Capital spending−₩15.85bn−₩8.79bn−₩7.21bn−₩63.99bn−₩16.27bn−₩3.08bn−₩12.85bn−₩12.68bn−₩8.72bn
Free cash flow−₩4.80bn−₩5.08bn−₩327.7m−₩49.82bn−₩10.11bn−₩1.52bn−₩20.96bn−₩18.61bn−₩10.30bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩20.08bn₩16.00bn₩20.38bn₩20.12bn₩20.57bn₩15.83bn₩19.03bn₩14.96bn
Operating income₩2.31bn−₩665.3m₩5.48bn₩1.02bn₩1.77bn−₩876.0m—−₩464.4m
Net income₩1.60bn−₩2.13bn₩2.28bn−₩3.08bn−₩2.14bn−₩3.66bn₩4.52bn−₩3.27bn
Diluted earnings per share42.90-57.3061.28-85.77-59.75-102.19126.29-91.53
Cash from operations₩4.57bn−₩1.58bn₩126.0m₩3.77bn₩6.85bn₩301.0m₩3.72bn−₩2.28bn
Capital spending−₩2.33bn−₩3.26bn−₩2.70bn−₩6.32bn−₩2.98bn−₩3.85bn−₩8.79bn−₩1.66bn
Free cash flow₩2.23bn−₩4.85bn−₩2.57bn−₩2.55bn₩3.87bn−₩3.55bn−₩5.08bn−₩3.94bn
Total assets₩243.65bn₩212.23bn₩209.14bn₩218.30bn₩235.02bn₩219.24bn₩222.72bn₩228.35bn
Cash and short-term investments—————₩19.61bn₩23.90bn₩27.20bn
Debt₩69.59bn₩54.10bn₩50.10bn₩50.10bn₩50.10bn₩17.91bn₩18.05bn₩18.39bn
Shareholders' equity₩81.63bn₩72.46bn₩65.46bn₩63.23bn₩66.18bn₩68.82bn₩72.28bn₩66.74bn

Financial ratios

Data as of 2 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating margin5.0%———6.9%-41.1%-80.8%-40.6%
Net margin-8.6%-0.3%23.8%3.2%32.8%-45.1%——
Return on equity-10.1%-0.3%19.5%2.6%19.9%-22.4%——
Return on assets-3.2%-0.1%5.7%0.8%7.4%-13.9%——
Revenue growth12.2%16.7%27.7%38.4%60.8%55.3%——
Earnings growth3407.4%-101.3%859.9%-86.6%-216.7%-36.7%——
Current ratio0.37x0.36x0.72x0.58x3.19x1.72x——
Debt to equity0.77x0.25x0.99x1.12x1.01x0.33x——
Equity ratio31.3%32.5%29.3%30.2%36.9%62.2%——
Interest coverage0.36x———0.62x-13.76x——
R&D as a share of sales13.0%14.3%17.4%13.6%11.8%24.5%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue18.7%30.1%—
Net income—-6.7%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings-34.5-1473.29.980.216.7-21.6-5.7
Price to sales3.04.02.42.55.59.76.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-for-1 split · 3 Jan 2025
  • 2-for-1 split · 25 Jun 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.